Flea And Tick Product (Unknown)

Verify with FDA CVM →

249 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
249
Total Reports
13
Deaths Reported
520.0%
Death Rate

Active Ingredients

Flea And Tick Product (Unknown)

Administration Routes

UnknownTopicalOralCutaneousOther

Species Affected

Dog 214
Cat 35

Most Affected Breeds

Retriever - Labrador 29
Domestic Shorthair 23
Pit Bull 16
Shepherd Dog - German 12
Chihuahua 11
Crossbred Canine/dog 11
Shih Tzu 10
Dog (unknown) 10
Retriever - Golden 9
Terrier - Yorkshire 6

Most Reported Reactions

Vomiting 46
Lack of efficacy (flea) 29
Lack of efficacy (ectoparasite) - flea 23
Lack of efficacy (endoparasite) - heartworm 18
Lethargy (see also Central nervous system depression in 'Neurological') 17
Diarrhoea 17
Behavioural disorder NOS 15
Not eating 12
Decreased appetite 11
Lack of efficacy (endoparasite) - hookworm 10
Not drinking 10
Other abnormal test result NOS 9

Outcome Breakdown

Outcome Unknown
137 (54.8%)
Recovered/Normal
50 (20.0%)
Ongoing
47 (18.8%)
Died
8 (3.2%)
Euthanized
5 (2.0%)
Recovered with Sequela
3 (1.2%)

Data Summary

Metric Value
Total adverse event reports 249
Reports involving death 13
Case-fatality rate (reported events) 520.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Flea And Tick Product (Unknown) Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 249 adverse event reports referencing Flea And Tick Product (Unknown), including 13 reports in which the animal died — a 520.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Flea And Tick Product (Unknown). Reported administration routes include Unknown, Topical, Oral, Cutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Flea And Tick Product (Unknown) reports are Dog (214 reports), Cat (35 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (29), Domestic Shorthair (23), Pit Bull (16) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Flea And Tick Product (Unknown) are Vomiting (46), Lack of efficacy (flea) (29), Lack of efficacy (ectoparasite) - flea (23), Lack of efficacy (endoparasite) - heartworm (18). Of the 250 reports with a coded outcome, Outcome Unknown is the leading category at 54.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Flea And Tick Product (Unknown).

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial